Is the weight loss injection safe? Here is what the evidence actually shows

Both tirzepatide and semaglutide hold MHRA licences for weight management in the UK and carry Black Triangle (▼) status, meaning the MHRA actively monitors post-market safety data.
The most commonly reported side effects are gastrointestinal (nausea, loose stools, constipation) and tend to be most noticeable in the first weeks of treatment or after a dose increase.
Serious events such as acute pancreatitis are documented and require prompt medical attention; the MHRA issued a specific Drug Safety Update on this risk in January 2026.
Buying these medicines from unverified online sellers carries genuine danger: fake pens have been found to contain insulin, and the MHRA seized roughly 20 million doses of illegally traded weight-loss medicines in 2025 alone.

Weight loss injections licensed in the UK — tirzepatide (Mounjaro) and semaglutide (Wegovy) — have been studied in large clinical trials and reviewed by the MHRA, NICE and the NHS. They carry real side effects, mostly gastrointestinal, which affect many users and are usually mild and temporary. Serious risks exist but are uncommon. For most adults who meet the clinical criteria, the medicines are considered safe to use under prescriber supervision. They are prescription-only, which means a qualified clinician must assess your full health picture before treatment starts, and that assessment is where safety begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the safety evidence covers, and where the real risks sit

You've read the headlines and you want a straight answer

Maybe a colleague at work has started one of these injections and you're wondering whether it's right for you. Or you've seen alarming social-media posts and aren't sure what to believe. Either way, the question is reasonable: these are medicines, and medicines carry risk.

The clinical picture for tirzepatide and semaglutide is detailed and well-documented. Tirzepatide was tested in the SURMOUNT programme, which enrolled thousands of adults across multiple trials. Semaglutide's STEP 1 trial ran for 68 weeks across a similarly large population. The NHS tirzepatide page and the NHS semaglutide page both list the known side effects clearly, drawing on the same datasets regulators used to grant UK licences.

The short version: these medicines are not free of side effects, and they are not suitable for everyone. But for adults who meet the clinical criteria and are supervised by a prescriber, the evidence supports their use as safe, in the same considered way any prescription medicine can be called safe. The prescriber's job is to weigh your individual health picture against the known risks. That is precisely why they require a prescription.

If you want to understand what supervised treatment actually involves, our treatment options page walks through how the process works.

Side effects: what most people experience, and what to watch for

The most common side effects of weight loss injections are gut-related. Nausea is the one most people mention first. Loose stools, constipation, indigestion, burping and fatigue also appear regularly in trial data, and injection-site reactions are possible. These effects tend to cluster in the first week or two after starting treatment or moving up a dose, then settle for most people.

That pattern is one reason the dosing schedule starts low. The initial dose exists to let your body adjust; it is not where the treatment's main effect comes from. Titration happens gradually, guided by your prescriber.

Rarer but more serious side effects include acute pancreatitis. The MHRA's Drug Safety Update of 29 January 2026 specifically highlighted this risk for GLP-1 medicines: severe, persistent stomach pain that spreads towards the back (with or without vomiting) needs prompt medical assessment, not a wait-and-see approach. Other signals to take seriously include symptoms of gallbladder problems, signs of dehydration from repeated vomiting or diarrhoea, and any allergic reaction.

There is more detail on the full side-effect profile in our guide to using weight loss injections safely, and if you are wondering whether weight loss injections are safe given your own circumstances, our dedicated page covers the key considerations on individual risk in detail.

When to seek medical help without delay

Most side effects from weight loss injections are uncomfortable rather than dangerous. A few are not.

Get urgent medical help if you experience: severe abdominal pain that is persistent or radiates to the back; signs of a serious allergic reaction such as swelling of the face, lips or throat, difficulty breathing or a rapid heart rate; symptoms of acute dehydration after prolonged vomiting or diarrhoea, including very dark urine, dizziness on standing or not passing urine; or any new or worsening thoughts of self-harm.

Contact your prescriber or GP (not necessarily urgently, but promptly) for ongoing nausea that is stopping you eating normally, persistent constipation, or any symptom that concerns you between consultations.

You can also report any suspected side effect directly via the MHRA's Yellow Card scheme. That reporting system is how regulators track signals that emerge after a medicine reaches wider use, and it matters: the MHRA's ongoing monitoring of tirzepatide and semaglutide relies partly on patients and clinicians submitting these reports.

If you're unsure where your symptom sits, our support team is available seven days a week, and prescribers at nume (sorry, at nume) can advise through the aftercare pathway.

The safety risk nobody talks about enough: where your medicine actually comes from

Clinical trial data covers medicines made and handled correctly. A pen bought from an unverified seller on social media is a different matter entirely.

The MHRA has documented serious harm from counterfeit weight-loss pens, including cases where fake pens contained insulin rather than the labelled medicine. In 2025, enforcement action uncovered roughly 20 million doses of illegally traded weight-loss medicines with a street value of around £45 million, including the first illicit UK manufacturing site producing counterfeit tirzepatide pens, raided in Northampton. The MHRA's guidance is clear: buy only from a pharmacy you can verify.

Checking is straightforward. Every legitimate UK online pharmacy is listed on the GPhC register; you can verify a pharmacy at pharmacyregulation.org/registers. Sellers offering these medicines without a prescription, with deeply discounted pricing or via social-media DMs are red flags. If you have come across a weight loss injection being promoted through an unverified channel and want to understand what a legitimately dispensed option actually looks like, our product page explains what a properly supplied treatment involves. A discount code for a prescription-only medicine from an unverified source is not a bargain, it is a warning sign.

Genuine safety comes from a genuine supply chain: licensed medicines, dispensed by a GPhC-registered pharmacy, following a clinical assessment by a real prescriber. That is the only combination that delivers the medicine the trials studied. Many people asking whether the new weight loss injections are safe are surprised to find that the supply chain question matters as much as the clinical data itself, a point our prescribers discuss as part of every consultation. Our prescribers also cover suitability and side effects during that process, and if you want to go deeper on whether it is safe to take injections for weight loss given your personal health history, our dedicated page works through the key factors before you commit to anything. You can also start your free consultation to speak with the team.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions